The definition and diagnostic criteria of hepatorenal syndrome-acute kidney injury (HRS-AKI) has undergone recent changes. A major vasoconstrictor, terlipressin, has recently been approved as pharmacotherapy for HRS-AKI in the United States. The purpose of this review is to familiarize the readers with these new diagnostic criteria of HRS-AKI, and how best to use terlipressin.

中文翻译：

---

特利加压素用于肝肾综合征。

肝肾综合征-急性肾损伤（HRS-AKI）的定义和诊断标准最近发生了变化。特利加压素是一种主要的血管收缩剂，最近在美国被批准作为 HRS-AKI 的药物治疗。本综述的目的是让读者熟悉 HRS-AKI 的这些新诊断标准，以及如何最好地使用特利加压素。